CH

Catella Healthcare Investments

Europe, Stockholms Lan, Sweden, Stockholm

Description

Catella Healthcare Investments is a Swedish investment firm that offers middle and late stage investments.

Investor Profile

Catella Healthcare Investments has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series E, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States, Sweden.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series E (50%)
  • Series Unknown (50%)

Country Focus

  • United States (50%)
  • Sweden (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Catella Healthcare Investments frequently co-invest with?

Thomas Weisel Venture Partners
North America, California, United States, San Francisco
Co-Investments: 1
InterWest Partners
North America, California, United States, Menlo Park
Co-Investments: 1
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 1
HB Ventures
Asia, Beijing, China, Gaobeidian
Co-Investments: 1
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 1
Hercules Capital
North America, California, United States, San Mateo
Co-Investments: 1
BV
North America, California, United States, San Diego
Co-Investments: 1
TL Ventures
North America, Pennsylvania, United States, Wayne
Co-Investments: 1
SC
North America, Texas, United States, Austin
Co-Investments: 1

What are some of recent deals done by Catella Healthcare Investments?

QuatRx Pharmaceuticals

Ann Arbor, Michigan, United States

QuatRx Pharmaceuticals Company, a biopharmaceutical company, engages in discovering, licensing, developing, and commercializing compounds

BiotechnologyHealth CarePharmaceutical
Series EMay 22, 2007
Amount Raised: $44,000,000
Cellartis

Göteborg, Vastra Gotaland, Sweden

Cellartis develops human embryonic stem cells and technology for drug discovery research, toxicity testing and regenerative medicine.

Biotechnology
Series UnknownDec 13, 2005
Amount Raised: $9,553,414